<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9811707</PMID><DateCompleted><Year>1998</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>72</Volume><Issue>12</Issue><PubDate><Year>1998</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Study of Dengue virus infection in SCID mice engrafted with human K562 cells.</ArticleTitle><Pagination><StartPage>9729</StartPage><EndPage>9737</EndPage><MedlinePgn>9729-37</MedlinePgn></Pagination><Abstract><AbstractText>Here we report that severe combined immunodeficient (SCID) mice engrafted with human K562 cells (K562-SCID mice) can be used as an animal model to study dengue virus (DEN) infection. After intratumor injection into K562 cell masses of PL046, a Taiwanese DEN-2 human isolate, the K562-SCID mice showed neurological signs of paralysis and died at approximately 2 weeks postinfection. In addition to being detected in the tumor masses, high virus titers were detected in the peripheral blood and the brain tissues, indicating that DEN had replicated in the infected K562-SCID mice. In contrast, the SCID mice were resistant to DEN infection and the mock-infected K562-SCID mice survived for over 3 months. These data illustrate that DEN infection contributed directly to the deaths of the infected K562-SCID mice. Other serotypes of DEN were also used to infect the K562-SCID mice, and the mortality rates of the infected mice varied with different challenge strains, suggesting the existence of diverse degrees of virulence among DENs. To determine whether a neutralizing antibody against DEN in vitro was also protective in vivo, the K562-SCID mice were challenged with DEN-2 and received antibody administration at the same time or 1 day earlier. Our results revealed that the antibody-treated mice exhibited a reduction in mortality and a delay of paralysis onset after DEN infection. In contrast to K562-SCID, the persistently DEN-infected K562 cells generated in vitro invariably failed to be implanted in the mice. It seems that in the early stage of implantation, a gamma interferon activated, nitric oxide-mediated anti-DEN effect might play a role in the innate immunity against DEN-infected cells. The system described herein offers an opportunity to explore DEN replication in vivo and to test various antiviral protocols in infected hosts.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Y L</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, National Taiwan University, Taipei, Taiwan, Republic of China. yll@ibms.sinica.edu.tw</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>C L</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>L K</ForeName><Initials>LK</Initials></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>C T</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>C I</ForeName><Initials>CI</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>S H</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Y Y</ForeName><Initials>YY</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Y L</ForeName><Initials>YL</Initials></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>C L</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>C C</ForeName><Initials>CC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020014" MajorTopicYN="N">K562 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016513" MajorTopicYN="N">Mice, SCID</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009368" MajorTopicYN="N">Neoplasm Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012703" MajorTopicYN="N">Serotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014183" MajorTopicYN="N">Transplantation, Heterologous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014766" MajorTopicYN="N">Viremia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1998</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1998</Year><Month>11</Month><Day>13</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1998</Year><Month>11</Month><Day>13</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9811707</ArticleId><ArticleId IdType="pmc">PMC110483</ArticleId><ArticleId IdType="doi">10.1128/JVI.72.12.9729-9737.1998</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akarid K, Sinet M, Desforges B, Gougerot-Pocidalo M A. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J Virol. 1995;69:7001&#x2013;7005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189619</ArticleId><ArticleId IdType="pubmed">7474119</ArticleId></ArticleIdList></Reference><Reference><Citation>Amano T, Richelson E, Nirenberg M. Neurotransmitter synthesis by neuroblastoma clones. Proc Natl Acad Sci USA. 1972;69:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC427587</ArticleId><ArticleId IdType="pubmed">4400294</ArticleId></ArticleIdList></Reference><Reference><Citation>Amor S, Scallan M F, Morris M M, Dyson H, Fazakerley J K. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J Gen Virol. 1996;77:281&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">8627232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi Z, Reiss C S. Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol. 1995;69:2208&#x2013;2213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC188889</ArticleId><ArticleId IdType="pubmed">7533852</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonpucknavig S, Vuttiviroj O, Boonpucknavig V. Infection of young adult mice with dengue virus type 2. Trans R Soc Trop Med Hyg. 1981;75:647&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">7036427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosma G C, Custer R P, Bosma M J. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301:527&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">6823332</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt W E, McCown J M, Gentry M K, Russell P K. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun. 1982;36:1036&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC551436</ArticleId><ArticleId IdType="pubmed">6284641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers T J, Hahn C S, Galler R, Rice C M. Flavivirus genome, organization, expression, and replication. Annu Rev Microbiol. 1990;44:649&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">2174669</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L-K, Liao C-L, Lin C-G, Lai S-C, Liu C-I, Ma S-H, Huang Y-Y, Lin Y-L. Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells. Virology. 1996;217:220&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">8599206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L-K, Lin Y-L, Liao C-L, Lin C-G, Huang Y-L, Yeh C-T, Lai S-C, Jan J-T, Chin C. Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro. Virology. 1996;223:79&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">8806542</ArticleId></ArticleIdList></Reference><Reference><Citation>Croen K D. Evidence for antiviral effect of nitric oxide: inhibition of herpes simplex virus type-1 replication. J Clin Investig. 1993;91:2446&#x2013;2452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC443304</ArticleId><ArticleId IdType="pubmed">8390481</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer G, Stewart S A, Baird S M, Lee F, Feuer R, Chen I S. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J Virol. 1995;69:1328&#x2013;1333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC188715</ArticleId><ArticleId IdType="pubmed">7815516</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler D J. Dengue viruses. In: Webster R G, Granoff A, editors. Encyclopedia of virology. San Diego, Calif: Academic Press, Inc.; 1994. pp. 324&#x2013;331.</Citation></Reference><Reference><Citation>Halevy M, Akov Y, Ben-Nathan D, Kobiler D, Lachmi B, Lustig S. Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch Virol. 1994;137:355&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">7944955</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S B, O&#x2019;Rourke E J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977;146:201&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2180729</ArticleId><ArticleId IdType="pubmed">406347</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis. 1979;140:527&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">117061</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S B, Venkateshan C N, Gentry M K, Larsen L K. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol. 1984;132:1529&#x2013;1532.</Citation><ArticleIdList><ArticleId IdType="pubmed">6607288</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S B. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">3277268</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S B. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis. 1989;11:S830&#x2013;S839.</Citation><ArticleIdList><ArticleId IdType="pubmed">2665015</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris N, Buller R M, Karupiah G. Gamma interferon-induced nitric oxide-mediated inhibition of vaccinia virus replication. J Virol. 1995;69:910&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC188659</ArticleId><ArticleId IdType="pubmed">7529336</ArticleId></ArticleIdList></Reference><Reference><Citation>Karupiah G, Xie Q W, Buller R M, Nathan C, Duarte C, MacMicking J D. Inhibition of viral replication by interferon-&#x3b3;-induced nitric oxide synthase. Science. 1993;261:1445&#x2013;1448.</Citation><ArticleIdList><ArticleId IdType="pubmed">7690156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler G, Milstein C. Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur J Immunol. 1976;6:511&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">825374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Innis B L, Nimmannitya S, Nisalak A, Rothman A L, Livingston P G, Janus J, Ennis F A. Human immune responses to dengue viruses. Southeast Asian J Trop Med Public Health. 1990;21:658&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pubmed">1983049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Kontny U, Janus J, Ennis F A. Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infection. Arch Virol. 1990;110:91&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">2178591</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Ennis F A. Immunity and immunopathology in dengue virus infections. Semin Immunol. 1992;4:121&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">1617166</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-L, Huang Y-L, Ma S-H, Yeh C-T, Chiou S-Y, Chen L-K, Liao C-L. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol. 1997;71:5227&#x2013;5235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191758</ArticleId><ArticleId IdType="pubmed">9188590</ArticleId></ArticleIdList></Reference><Reference><Citation>Littaua R, Kurane I, Ennis F A. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol. 1990;144:3183&#x2013;3186.</Citation><ArticleIdList><ArticleId IdType="pubmed">2139079</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozzio B B, Lozzio C B, Bamberger E G, Feliu A S. A multipotential leukemia cell line (K-562) of human origin. Proc Soc Exp Biol Med. 1981;166:546&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">7194480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum L C, Lam S K, Choy Y S, George R, Harum F. Dengue encephalitis: a true entity? Am J Trop Med Hyg. 1996;54:256&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">8600761</ArticleId></ArticleIdList></Reference><Reference><Citation>Monath T P. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci USA. 1994;91:2395&#x2013;2400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC43378</ArticleId><ArticleId IdType="pubmed">8146129</ArticleId></ArticleIdList></Reference><Reference><Citation>Monath T P, Heinz F X. Flaviviruses. In: Fields B N, Knipe D M, Howley P M, et al., editors. Fields virology. 3rd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1996. pp. 961&#x2013;1034.</Citation></Reference><Reference><Citation>Mosier D E. Immunodeficient mice xenografted with human lymphoid cells: new models for in vivo studies of human immunobiology and infectious diseases. J Clin Immunol. 1990;10:185&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">1976649</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosier D E. Viral pathogenesis in hu-PBL-SCID mice. Semin Immunol. 1996;8:255&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">8883149</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmannitya S, Thisyakorn U, Hemsrichart V. Dengue haemorrhagic fever with unusual manifestations. Southeast Asian J Trop Med Public Health. 1987;18:398&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">3433170</ArticleId></ArticleIdList></Reference><Reference><Citation>Patey O, Ollivaud L, Breuil J, Lafaix C. Unusual neurologic manifestations occurring during dengue fever infection. Am J Trop Med Hyg. 1993;48:793&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">8333572</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisa P, Sitnicka E, Hansson M. Activated natural killer cells suppress myelopoiesis in mice with severe combined immunodeficiency. Scand J Immunol. 1993;37:529&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">8469936</ArticleId></ArticleIdList></Reference><Reference><Citation>Porterfield J S. Antibody-dependent enhancement of viral infectivity. Adv Virus Res. 1986;31:335&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">2428214</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice C M. Flaviviridae: the viruses and their replication. In: Fields B N, Knipe D M, Howley P M, et al., editors. Fields virology. 3rd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1996. pp. 931&#x2013;959.</Citation></Reference><Reference><Citation>Row D, Weinstein P, Murray-Smith S. Dengue fever with encephalopathy in Australia. Am J Trop Med Hyg. 1996;54:253&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">8600760</ArticleId></ArticleIdList></Reference><Reference><Citation>Russel P K, Nisalak A. Dengue virus identification by the plaque reduction neutralisation test. J Immunol. 1967;99:291&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">4961907</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabin A B, Schlesinger R W. Production of immunity to dengue with virus modified by propagation in mice. Science. 1945;101:640&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">17844088</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger R W. Dengue viruses. New York, N.Y: Springer-Verlag; 1977. pp. 72&#x2013;73.</Citation></Reference><Reference><Citation>Sinniah M, Igarashi A. Dengue haemorrhagic fever. Rev Med Virol. 1995;5:193&#x2013;203.</Citation></Reference><Reference><Citation>Wissman C L, Jr, Sweet B H, Rosenzweig E C, Eylar O R. Attenuated living type 1 dengue vaccines. Am J Trop Med Hyg. 1963;12:620&#x2013;623.</Citation></Reference><Reference><Citation>Wu S-J L, Hayes C G, Dubois D R, Windheuser M G, Kang Y-H, Watts D M, Sieckmann D G. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am J Trop Med Hyg. 1995;52:468&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">7771614</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>